Patheon   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Amsterdam Netherlands (1974)
Status: Acquired by Thermo Fisher Scientific (2017)

Organization Overview

First Clinical Trial
None
First Marketed Drug
2023
naproxen (naprosyn)
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

PATHEON SOFTGELS